← Leaderboards
David Proud
Johns Hopkins University
$579,092
Attributed
$579,092
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$579,092 · 3
By mechanism
R01$304,815 · 1
P01$209,108 · 1
M01$65,169 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Robert P Schleimer$28,154,309
- Andrew P Lane$17,085,410
- Richard A Cone$17,702,134
- Deborah J Anderson$20,708,269
- Marsha W Wills-Karp$29,249,566
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchRespiratory EpitheliumHuman SubjectSinusitisChronic Disease /DisorderInflammationRespiratory HypersensitivityNitric Oxide SynthaseGlucocorticoidsVirus Infection MechanismCellular PathologyChemokineColony Stimulating FactorCytokineDisease /Disorder EtiologyEosinophiliaGenetic SusceptibilityLongitudinal Human StudyMucusNeutrophilParanasal SinusPathologic ProcessPolymerase Chain ReactionProtein Biosynthesis
Grant awards (7)
EPITHELIAL FUNCTION AND DYSFUNCTION IN CHRONIC SINUSITIS$0
M01 · FY2002 · RR
VIRAL MODULATION OF EPITHELIAL FUNCTION$0
P01 · FY2002 · AI
EPITHELIAL FUNCTION AND DYSFUNCTION IN CHRONIC SINUSITIS$0
M01 · FY2001 · RR
VIRAL MODULATION OF EPITHELIAL FUNCTION$0
P01 · FY2001 · AI
KININS AS MEDIATORS OF HUMAN REACTIONS$304,815
R01 · FY2000 · HL
VIRAL MODULATION OF EPITHELIAL FUNCTION$209,108
P01 · FY2000 · AI
EPITHELIAL FUNCTION AND DYSFUNCTION IN CHRONIC SINUSITIS$65,169
M01 · FY2000 · RR